Skip to content
Screener

Incyte INCY Return on equity

Return on equity at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
46.7%+17.8pp
Pfizer logo
PfizerPFE
10.6%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
-48.9%-498pp
Gilead Sciences logo
Gilead SciencesGILD
43.2%+10.7pp
Geron logo
GeronGERN
-27.1%-7.8pp
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
-17.1%-26.1pp

Other financials

Income statement

See full
Revenue$1.7B+37.7%
Gross profit$1.6B+38.0%
Operating income$697.9M+31.6%
Net income$585.6M+44.6%
EPS (diluted)$2.81+37.7%

Balance sheet

See full
Cash & equivalents$4.0B+104%
Total debt$38.3M-9.8%
Total equity$6.3B+52.1%
Total assets$7.9B+35.2%

Cash flow

See full
Operating cash flow$507.7M+1,035%
CapEx$1.6M-43.5%
Free cash flow$509.3M+1,069%

Valuation

See full
Market cap$24.23B+59.0%
Enterprise value$20.28B+52.2%
P/E15×-2.5×
P/S4.2×+0.8×

Profitability

See full
Gross margin92.6%-0.3pp
Operating margin30.6%+4.8pp
Net margin27.7%+8.7pp
FCF margin34%+12.3pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio4.6×+1.7×

Where this comes from

Calculated from Incyte’s reported figures.

Based on trailing twelve months.

The source filing: Incyte’s 10-Q, filed July 28, 2026. Open the filing →

Filed
Jul 28, 2026, 4:02 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000879169-26-000056

FAQ

What is Incyte's return on equity?
Incyte (INCY) reported return on equity of 30.7% in Q2 2026.
How has Incyte's return on equity changed year-over-year?
Incyte's return on equity increased by 26.2% year-over-year, from 24.3% to 30.7%.
What is the long-term trend for Incyte's return on equity?
Over 5 years (2020 to 2025), Incyte's return on equity has grown at a 21.3% compound annual growth rate (CAGR), from -11.4% to 29.9%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Incyte's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude